全球连续血糖监测仪市场规模、份额、趋势和成长分析报告（2026-2034年）

预计持续血糖监测市场将从 2025 年的 156.3 亿美元成长到 2034 年的 578.1 亿美元，2026 年至 2034 年的复合年增长率为 15.64%。

受全球糖尿病患者人数不断增加的推动，全球持续血糖监测市场正经历快速成长。持续血糖监测系统可全天即时测量血糖值，为患者和医疗专业人员提供有关血糖值波动模式的重要资讯。这些设备有助于患者及时调整饮食、药物和生活方式，进而改善糖尿病管理。

市场成长主要受全球糖尿病盛行率上升和对先进监测技术需求不断增长的推动。与传统血糖检测法相比，连续血糖监测仪能够提供更准确、更连续的数据。穿戴式感测器技术的进步以及与行动应用程式的集成，也提高了患者的便利性和监测效率。

随着数位健康技术的不断发展，持续血糖监测市场前景十分广阔。与智慧胰岛素输注系统和行动医疗平台的整合，有望实现更个人化的糖尿病管理。此外，发展中国家糖尿病医疗意识的提高和医疗服务覆盖范围的扩大也将推动市场成长。随着技术进步提升病患监测能力，持续血糖监测系统将在糖尿病治疗中发挥至关重要的作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球连续血糖监测仪市场：依组件划分

• 市场分析、洞察与预测
• 感应器
• 发送器
• 接收器

第五章：全球连续血糖监测仪市场：依年龄组别划分

• 市场分析、洞察与预测
• 成人
• 儿童

第六章 全球连续血糖监测仪市场：依最终用户划分

• 市场分析、洞察与预测
• 居家医疗环境
• 医院和诊所

第七章 全球连续血糖监测仪市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • DexCom Inc
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Medironic. Plc
  • Nemaura Medical Inc
  • LifeScan Inc
  • Senseonics Holdings Inc.（US）
  • A Menarini Diagnostics Srl
  • Medtrum. Technologies Inc
  • B. Braun SE

The Continuous Glucose Monitoring Meter Market size is expected to reach USD 57.81 Billion in 2034 from USD 15.63 Billion (2025) growing at a CAGR of 15.64% during 2026-2034.

The global continuous glucose monitoring meter market has experienced rapid growth due to increasing cases of diabetes worldwide. Continuous glucose monitoring systems measure glucose levels in real time throughout the day, providing patients and healthcare providers with valuable insights into blood sugar patterns. These devices help improve diabetes management by allowing patients to make timely adjustments to diet, medication, and lifestyle.

Market growth is driven by the rising global prevalence of diabetes and the increasing demand for advanced monitoring technologies. Continuous glucose monitoring meters provide more accurate and continuous data compared to traditional blood glucose testing methods. The development of wearable sensors and mobile application connectivity has also improved patient convenience and monitoring efficiency.

The future of the continuous glucose monitoring meter market appears highly promising as digital health technologies continue to evolve. Integration with smart insulin delivery systems and mobile health platforms may enable more personalized diabetes management. Increasing healthcare awareness and expanding access to diabetes care in developing regions will also support market growth. As technology improves patient monitoring capabilities, continuous glucose monitoring systems will play a vital role in diabetes care.

MARKET SEGMENTATION

By Component

• Sensors
• Transmitters
• Receivers

By Age Group

• Adults
• Children

By End User

• Home Care Settings
• Hospitals and Clinics

COMPANIES PROFILED

• DexCom Inc, Abbott Laboratories, F HoffmannLa Roche Ltd, Medironic plc, Nemaura Medical Inc, LifeScan Inc, Senseonics Holdings Inc US, A Menarini Diagnostics Srl, Medtrum Technologies Inc, B Braun SE
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CONTINUOUS GLUCOSE MONITORING METER MARKET: BY COMPONENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Component
• 4.2. Sensors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Transmitters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Receivers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CONTINUOUS GLUCOSE MONITORING METER MARKET: BY AGE GROUP 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Age Group
• 5.2. Adults Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Children Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CONTINUOUS GLUCOSE MONITORING METER MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CONTINUOUS GLUCOSE MONITORING METER MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Component
  • 7.2.2 By Age Group
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Component
  • 7.3.2 By Age Group
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Component
  • 7.4.2 By Age Group
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Component
  • 7.5.2 By Age Group
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Component
  • 7.6.2 By Age Group
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CONTINUOUS GLUCOSE MONITORING METER INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 DexCom Inc
  • 9.2.2 Abbott Laboratories
  • 9.2.3 F. Hoffmann-La Roche Ltd
  • 9.2.4 Medironic. Plc
  • 9.2.5 Nemaura Medical Inc
  • 9.2.6 LifeScan Inc
  • 9.2.7 Senseonics Holdings Inc. (US)
  • 9.2.8 A Menarini Diagnostics Srl
  • 9.2.9 Medtrum. Technologies Inc
  • 9.2.10 B. Braun SE